Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 256 AL 270

Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: a systematic review and meta-analysis

Soysal P, Isik AT, Stubbs B, Solmi M, Volpe M, Luchini C, D'Onofrio G, Pilotto A, Manzato E, Sergi G, Schofield P, Veronese N.

J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1368-1374. doi: 10.1136/jnnp-2016-313660. Epub 2016 Jun 3.

Is pain sensitivity altered in people with Alzheimer's disease? A systematic review and meta-analysis of experimental pain research

Stubbs B, Thompson T, Solmi M, Vancampfort D, Sergi G, Luchini C, Veronese N.

Exp Gerontol. 2016 Sep;82:30-8. doi: 10.1016/j.exger.2016.05.016. Epub 2016 Jun 2.

Astrocytic and microglial nicotinic acetylcholine receptors: an overlooked issue in Alzheimer's disease

Sadigh-Eteghad S, Majdi A, Mahmoudi J, Golzari SEJ, Talebi M.

J Neural Transm (Vienna). 2016 Dec;123(12):1359-1367. doi: 10.1007/s00702-016-1580-z. Epub 2016 Jun 4.

The Brainstem Tau Cytoskeletal Pathology of Alzheimer's Disease: A Brief Historical Overview and Description of its Anatomical Distribution Pattern, Evolutional Features, Pathogenetic and Clinical Relevance

Rüb U, Stratmann K, Heinsen H, Turco DD, Seidel K, Dunnen Wd, Korf HW.

Curr Alzheimer Res. 2016;13(10):1178-97. doi: 10.2174/1567205013666160606100509.

The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease

Walker LC, Schelle J, Jucker M.

Cold Spring Harb Perspect Med. 2016 Jul 1;6(7):a024398. doi: 10.1101/cshperspect.a024398.

Polymorphisms of CHAT but not TFAM or VR22 are Associated with Alzheimer Disease Risk

Gao L, Zhang Y, Deng J, Yu W, Yu Y.

Med Sci Monit. 2016 Jun 7;22:1924-35. doi: 10.12659/msm.895984.

BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides

Choi RJ, Roy A, Jung HJ, Ali MY, Min BS, Park CH, Yokozawa T, Fan TP, Choi JS, Jung HA.

J Ethnopharmacol. 2016 Aug 22;190:219-30. doi: 10.1016/j.jep.2016.06.013. Epub 2016 Jun 5.

Common therapeutic strategies for prion and Alzheimer's diseases

Elezgarai SR, Biasini E.

Biol Chem. 2016 Nov 1;397(11):1115-1124. doi: 10.1515/hsz-2016-0190.

Normative data for phonemic and semantic verbal fluency test in the adult French-Quebec population and validation study in Alzheimer's disease and depression

St-Hilaire A, Hudon C, Vallet GT, Bherer L, Lussier M, Gagnon JF, Simard M, Gosselin N, Escudier F, Rouleau I, Macoir J.

Clin Neuropsychol. 2016 Oct;30(7):1126-50. doi: 10.1080/13854046.2016.1195014. Epub 2016 Jun 9.

Essential Oils and Pure Volatile Compounds as Potential Drugs in Alzheimer's Disease Therapy: An Updated Review of the Literature

Maggio A, Rosselli S, Bruno M.

Curr Pharm Des. 2016;22(26):4011-27. doi: 10.2174/1381612822666160607065917.

Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis

Xiao T, Jiao B, Zhang W, Tang B, Shen L.

CNS Drugs. 2016 Oct;30(10):899-907. doi: 10.1007/s40263-016-0356-1.

Upstream regulators and downstream effectors of NF-κB in Alzheimer's disease

Shi ZM, Han YW, Han XH, Zhang K, Chang YN, Hu ZM, Qi HX, Ting C, Zhen Z, Hong W.

J Neurol Sci. 2016 Jul 15;366:127-134. doi: 10.1016/j.jns.2016.05.022. Epub 2016 May 13.

Pharmacogenetic considerations in the treatment of Alzheimer's disease

Cacabelos R, Torrellas C, Teijido O, Carril JC.

Pharmacogenomics. 2016 Jun;17(9):1041-74. doi: 10.2217/pgs-2016-0031. Epub 2016 Jun 13.

Glutamate Receptors in Alzheimer's Disease: Mechanisms and Therapies

Anggono V, Tsai LH, Götz J.

Neural Plast. 2016;2016:8256196. doi: 10.1155/2016/8256196. Epub 2016 May 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias